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higher annual mortality rates caused by sepsis compared withMortality caused by sepsis in patients with end-stage renal
the GP, even after stratification for age, race, and DM. Conse-disease compared with the general population.
quently, this patient population should be considered at high-Background. In the United States, infection is second to
risk for the development of lethal sepsis.cardiovascular disease as the leading cause of death in patients
with end-stage renal disease (ESRD), and septicemia accounts
for more than 75% of this category. This increased susceptibil-
ity to infections is partly due to uremia, old age, and comorbid Infection is an important cause of morbidity and mor-conditions. Although it is intuitive to believe that mortality
tality among patients with end-stage renal disease (ESRD).caused by sepsis may be higher in patients with ESRD com-
In fact, the national U.S. Renal Data System (USRDS)pared with the general population (GP), no such data are
currently available. registry indicates that infection is the second leading
Methods. We compared annual mortality rates caused by cause of death in patients with ESRD following cardio-
sepsis in patients with ESRD (U.S. Health Care Financing vascular disease, and septicemia accounts for more thanAdministration 2746 death notification form) with those in the
75% of these infectious deaths [1].GP (death certificate). Data were abstracted from the U.S.
Patients with ESRD have a high incidence of bacterialRenal Data System (1994 through 1996 Special Data request)
and the National Center for Health Statistics. Data were strati- infections [2–4]. This increased susceptibility to bacterial
fied by age, gender, race, and diabetes mellitus (DM). Sensitiv- infections is due in part to the acquired immune defi-
ity analyses were performed to account for potential limitations ciency state of uremia, advanced age, and comorbid con-of the data sources.
ditions such as diabetes mellitus (DM), as well as theResults. Overall, the annual percentage mortality secondary
to sepsis was approximately 100- to 300-fold higher in dialysis frequent and repetitive exposure of patients to potential
patients and 20-fold higher in renal transplant recipients infectious risk factors during the normal course of dial-
(RTRs) compared with the GP. Mortality caused by sepsis was ysis therapy. One such example is repeated disruption
higher among diabetic patients across all populations. After
of the skin barrier. Consequently, although it is intuitivestratification for age, differences between groups decreased
to believe that mortality secondary to sepsis may bebut retained their magnitude. These findings remained robust
despite a wide range of sensitivity analyses. Indeed, mortality higher in patients with ESRD compared with the general
secondary to sepsis remained approximately 50-fold higher in population (GP), no such data are currently available.
dialysis patients compared with the GP, using multiple cause- In order to examine whether ESRD, per se, is associ-
of-death analyses; was approximately 50-fold higher in diabetic
ated with higher mortality secondary to sepsis, we ana-patients with ESRD compared with diabetic patients in the
lyzed annual mortality rates secondary to sepsis of patientsGP, when accounting for underreporting of DM on death cer-
tificates in the GP; and was approximately 30-fold higher in with ESRD treated by hemodialysis (HD), peritoneal di-
RTRs compared with the GP, when accounting for the incom- alysis (PD), and renal transplantation in the United
plete ascertainment of cause of death among RTRs. Further- States and compared them with those derived from themore, despite assignment of primary cause-of-death to major
GP. These analyses were stratified by age, race, gender,organ infections in the GP, annual mortality secondary to sepsis
and the presence of DM, and sensitivity analyses wereremained 30- to 45-fold higher in the dialysis population.
Conclusions. Patients with ESRD treated by dialysis have performed to account for potential limitations of the
data sources.
Key words: chronic renal failure, hemodialysis, peritoneal dialysis, kid-
ney transplantation, bacteremia, mortality.
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through 1996 and comprised a total of 50,227 deaths. This primary cause of death in both the NCHS and USRDS
special data request allowed the authors to divide septic files. Diabetic status in the GP was defined if ICD-9
deaths into deciles of age, according to gender, race, codes #250.0-250.9 were documented anywhere on the
and presence or absence of DM in the various target death certificate. It is important to note that the planned
populations, that is, HD, PD, and renal transplant recipi- analyses did not compare mortality rates among patients
ents (RTRs). To allow direct comparison with death presenting with sepsis who subsequently succumbed to
rates generated from the GP, for patients with ESRD, their illness, but rather annual percentage mortality sec-
death rates per 1000 patient years at risk were converted ondary to sepsis.
to the annual percentage mortality using the following
Sensitivity analysesformula:
Mortality secondary to sepsis may be underestimatedFraction dead at one year 5 1 2 e2 death rate
in the GP (relative to patients with ESRD), primarily
Since there is a clear inverse relationship between because of under-reporting of sepsis as the primary cause
dose of dialysis, as measured by urea kinetic modeling, of death in the GP. Consequently, sensitivity analyses
and mortality among patients with ESRD [5], we summa- were performed to capture more septic deaths in the
rized the dialysis characteristics of the patient popula- GP by combining “sepsis” or “bacteremia” ICD-9 codes
tion. For patients on maintenance HD, the mean urea documented anywhere on the death certificate and recal-
reduction ratio (URR) was 65.4% and delivered “single culating mortality rates in each subgroup of the GP (mul-
pool” Kt/V 1.19 [6]. For patients on maintenance PD, the tiple cause-of-death data). In addition, since many infec-
average weekly Kt/V was 1.95, and the weekly creatinine tious diseases are confined to specific organ systems, the
clearance was 62.9 L/week/1.73 m2 [6]. The overall na- use of the ICD-9 system does not readily allow assess-
tional trends in dose of dialysis in both the HD and ment of the aggregate impact of infectious diseases on
PD patient population increased steadily throughout the health statistics. Consequently, we performed additional
period included in this analysis (1994 through 1996). The sensitivity analyses to evaluate the overall burden of
U.S. distribution of dialyzers for the year 1996 consisted infectious diseases on mortality rates in the U.S. popula-
of synthetic (59%), modified cellulose (20%), and un- tion. In doing so, we minimized the risk of potential
modified cellulose (21%) membranes [6]. underreporting of mortality caused by sepsis in the GP
The GP mortality data were obtained from the Na- due to assignment of primary cause of death to specific
tional Center for Health Statistics (NCHS) for the year organ system diseases despite their infectious etiologies
1993 and comprised a total of 2.27 million deaths. The
(for example, pneumonia, pyelonephritis, cholecystitis,
NCHS data consisted of three sources: (1) the NCHS
and diverticulitis). The analyses were limited to ICD-9“Multiple Cause-of-Death File,” which allowed the au-
codes that were considered to be or result from an infec-thors to stratify the number of deaths secondary to sepsis
tious disease in all cases. We used a comprehensive listinto deciles of age according to gender, race, and the
of infectious disease syndromes that was previously pro-presence or absence of DM [7]; (2) the NCHS “Health
posed and categorized by Pinner et al [11]. We modifiedUnited States Population Statistics File,” which provided
the list by capturing more ICD-9 codes in each categorythe number of patients in each subgroup, and thereby,
(Appendix).in conjunction with the “Multiple Cause-of-Death File,”
Furthermore, there is known under-reporting of dia-allowed the calculation of mortality rates caused by sep-
betic status on death certificates in the NCHS databasesis in each subgroup [8]; and (3) The NCHS “National
[12]. Consequently, sensitivity analyses were also per-Health Interview Survey,” which allowed estimation of
formed in the diabetic and nondiabetic GP, and mortalitythe diabetic population in each subgroup, thereby per-
rates were recalculated assuming that DM was only doc-mitting the calculation of mortality rates in subgroups
umented on approximately 40% of diabetic patients’with and without DM [9].
death certificates [12].
Case definitions Finally, mortality secondary to sepsis may be underes-
timated in RTRs because of incomplete ascertainmentIn patients with ESRD, mortality secondary to sepsis
of cause of death in these patients. In fact, the USRDSwas defined using the U.S. Health Care Financing Ad-
has near complete ascertainment of cause of death inministration (HCFA) 2746 death notification form (#49-
patients currently receiving dialysis; however, causes of52). In the GP, mortality secondary to sepsis was defined
death in RTRs are only known in approximately 50%using the death certificate’s International Classification
of patients [1]. Consequently, mortality secondary to sep-of Diseases-9th (ICD-9) Modification diagnosis codes
sis in RTRs was recalculated in each subgroup, assumingfor sepsis (#038.0-038.9) and bacteremia (#790.7) as the
that the proportion of patients who died from sepsis wasunderlying causes of death [10]. Mortality secondary to
sepsis was included in the analyses only if sepsis was the similar in the subgroup of patients with unknown and
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Table 1. Annual mortality rates (%) secondary to sepsis stratified by gender, race and the presence or absence of diabetes mellitus in the
various target populations
All Men Women White Black Diabetic Nondiabetic
GP 0.008 0.007 0.009 0.008 0.011 0.020 0.008
GP-S1 0.041 0.040 0.043 0.040 0.057 0.141 0.038
GP-S2 0.067 0.074 0.060 0.065 0.091 0.112 0.065
GP-DM-S — — — — — 0.050 0.007
HD 2.117 1.921 2.332 2.332 1.951 2.732 1.725
PD 3.023 2.586 3.488 3.227 2.703 4.343 2.313
RTR 0.160 0.160 0.160 0.150 0.230 0.250 0.130
RTR-S 0.241 0.243 0.238 0.226 0.347 0.368 0.197
Abbreviations are: GP, general population; HD, hemodialysis; PD, peritoneal dialysis; RTR, renal transplant recipients; GP-S1, sensitivity analysis of mortality
due to sepsis (multiple cause-of-death data); GP-S2, sensitivity analysis of mortality due to infectious disease syndromes (including sepsis) in the general population
(Appendix A); GP-DM-S, sensitivity analysis of mortality due to sepsis of diabetic patients in the general population due to under-reporting of diabetes mellitus on
death certificates; RTR-S, sensitivity analysis of mortality due to sepsis in renal transplant recipients due to incomplete ascertainment of cause of death.
known causes of death. All of the results are presented
as annual percentage mortality.
RESULTS
Stratification analyses
As shown in Table 1, prior to stratification for age,
mortality secondary to sepsis was approximately 100- to
300-fold higher in HD and PD patients compared with
the GP. DM was associated with higher mortality caused
by sepsis across all populations. In the GP and in RTRs,
black race was associated with higher mortality rates Fig. 1. Mortality caused by sepsis of patients with end-stage renal dis-
caused by sepsis, whereas female gender and white race ease (ESRD) treated by dialysis compared with the general population
(GP). Data are stratified by age, gender (r, dialysis male; j, dialysiswere associated with more septic deaths in both HD
female; e, GP male; h, GP female), and race (m, dialysis black; d,and PD patients. However, gender, race, and DM were dialysis white; n, GP black; s, GP white), and are shown as annual
associated to a lesser degree with mortality caused by percentage mortality on a logarithmic scale.
sepsis when compared with “dialysis status” per se. An-
nual mortality rates in RTRs were approximately 20-
fold higher than those in the GP, but were much lower
Sensitivity analysesthan those in HD and PD patients.
Mortality secondary to sepsis remained approximatelyAfter stratification for age, mortality secondary to sep-
50-fold higher in HD and PD patients compared with thesis remained approximately 100-fold higher in patients
GP, despite accounting for the extreme case, where allwith ESRD treated by dialysis compared with the GP,
individuals with documented sepsis or bacteremia any-even among the old age groups (Fig. 1). Indeed, in the
where on the death certificate (multiple cause-of-death65 to 74 age group, annual mortality was 0.02% in the
data) were included in the analyses (GP-S1; Table 1). Fur-GP compared with 2.88% in the dialysis population.
thermore, despite assignment of primary cause of deathAfter stratification for gender, race, and age, the pres-
to major organ infections, annual mortality rates second-ence of DM was associated with higher mortality rates
ary to sepsis remained 30- to 45-fold higher in the dialysiscaused by sepsis in patients with ESRD treated by dial-
population compared with the GP (GP-S2; Table 1).ysis compared with patients without DM (Fig. 2). This
Mortality secondary to sepsis remained approximatelyeffect was magnified in the PD compared with the HD
50-fold higher in diabetic patients with ESRD comparedpatient population. Indeed, in the 65 to 74 age group,
with diabetic patients in the GP, despite accounting forthe annual mortality rate was 3.19 and 2.21% in diabetic
the under-reporting of DM on death certificates in theand nondiabetic HD patients, respectively. This con-
GP (GP-DM-S; Table 1).trasted with an annual mortality rate of 5.91 and 3.69%
Finally, after accounting for the incomplete ascertain-in diabetic and nondiabetic PD patients of the same age
ment of cause of death in RTRs, mortality secondary togroup, respectively (data not shown).
sepsis remained approximately 30-fold higher in RTRsFinally, compared with the GP, mortality secondary
compared with the GP and approximately 10-fold lowerto sepsis remained higher in RTRs despite stratification
for age (Fig. 3). compared with HD or PD patients (RTR-S; Table 1).
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Fig. 2. Mortality caused by sepsis of diabetic
(DM) and nondiabetic (no DM) patients with
ESRD treated by dialysis. (A) Data are strati-
fied by age and gender (r, male DM; j, fe-
male DM; e, male no DM; h, female no DM).
(B ) Data are stratified by age and race (m,
black DM; d, white DM; n, black no DM;
s, white no DM). Data are shown as annual
percentage mortality.
age, gender, race, and DM. The results suggest that mor-
tality rates secondary to sepsis are one to several hundred
fold higher in HD and PD patients compared with the
GP, despite stratification for age. The presence of ESRD,
per se, acted as a greater risk factor for septic deaths
compared with gender, race, or DM. In addition, stratifi-
cation for the latter three factors did not significantly
alter the magnitude of this difference. It is important to
note, however, that the difference in mortality between
the two groups cannot be solely ascribed to dialysis ac-
cess-related infections. Indeed, HD- and PD-related ac-
cess infections account for only 11 and 35% of deaths
secondary to sepsis, respectively [1]. Therefore, the pres-
Fig. 3. Mortality caused by sepsis of renal transplant recipients (RTRs) ence of “uremia” and its associated comorbid conditions,
compared with the general population (GP). Data are shown as annual including older age and DM, may partly account for
percentage mortality on a logarithmic scale and are stratified by age
these differences. In addition, in HD patients, dialysis-( , RTR; j, GP).
related factors, including dialysis membrane biocompati-
bility [17] and iron overload [18], may also be incrimi-
nated in a higher incidence of bacterial infections.
DISCUSSION Mortality secondary to sepsis in RTRs was also higher
It is well recognized that infection is a frequent cause compared with the GP but was lower compared with
of both morbidity and mortality in patients with ESRD HD and PD patients. The extent of these differences
on maintenance dialysis. In fact, most studies suggest persisted after stratification for age (Fig. 3). The lower
that infection is the second leading cause of death in mortality rates observed in RTRs compared with dialysis
patients with ESRD [1, 13]. This increased susceptibility patients may be due in part to a combination of selection
to infections has partly been ascribed to defective phago- bias toward transplantation (that is, patients who are
cytic function of granulocytes [14, 15], old age, and a transplanted are more likely to be healthy and have less
high prevalence of DM. In addition, dialysis patients comorbid conditions), disappearance of the uremic state
have frequent and repetitive exposure to potential infec- and its associated immunosuppressive state, and resolu-
tious risk factors during the normal course of dialysis tion of dialysis access-related infections.
therapy, which further predispose them to bacterial in- Although the USRDS provides accurate data on the
fections [2–4]. In a longitudinal cohort study of an inci- cause of death in more than 90% of patients with ESRD
dent ESRD patient population, Powe et al recently dem- who are currently on dialysis, causes of death are only
onstrated that older age and the presence of DM were known in approximately 50% of RTRs [1]. To account
the strongest predictors of risk for developing septicemia for this limitation, we performed a broad sensitivity anal-
in HD or PD patients [16]. ysis assuming that the causes of death in RTRs without
In our study, we evaluated the extent of the difference documented causes were similarly proportioned as in
in mortality caused by sepsis in patients with ESRD those with documented causes. Although this may not
be the most accurate representation, there is no reasoncompared with the GP, after stratifying the analyses for
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to suspect that the groups would dramatically differ. the HCFA 2746 death notification form and cause of death
using a classification system designed for the HEMOAfter performing these sensitivity analyses, mortality
rates in RTRs remained significantly higher and lower Study (abstract; Rocco et al, J Am Soc Nephrol 10:254A,
1999). In this comparative model, however, the disease-compared with the GP and dialysis patients, respectively.
The use of immunosuppressive drugs may account in specific agreement was best for malignancy, followed by
infectious and cardiovascular disease, respectively.part for the higher septic death rates observed in RTRs
compared with the GP. It has been suggested that comparisons of death cer-
tificate data with national registry data such as the HCFAAge and DM were associated with a higher rate of
septic deaths in both the GP and patients with ESRD. 2746 death notification form need to be interpreted with
great caution. Indeed, Perneger, Klag, and Whelton dem-This was true across all subgroups of patients with ESRD
regardless of dialysis modality, gender, or race (Figs. onstrated that the overall degree of agreement for cause
of death between death certificates and HCFA death1–3 and Table 1). These findings are consistent with the
known impairment of host defense mechanisms in old notification forms was only 31% [21]. Furthermore, dis-
ease-specific agreement was good for cancer, moderateand/or diabetic patients.
Diabetes mellitus is frequently not recorded on death for infectious disease, and poor for cardiovascular dis-
ease. One reason for this less-than-perfect agreementcertificates of persons with a history of the disease, which
may result in an underestimation of the contribution was that as many as 40% of primary causes of deaths
were classified as renal failure on the death certificate.of DM to overall mortality. This has particularly been
demonstrated by Bild and Stevenson in the NCHS data This compared with only 8% of deaths that were indi-
rectly attributed to renal failure on the HCFA death[12]. Consequently, to account for this known underre-
porting of DM, we performed a sensitivity analysis using notification form, including hyperkalemia, pericarditis,
and withdrawal from therapy [21]. Perneger, Klag, andthe aforementioned data generated by Bild and Steven-
son. Although a higher percentage of deaths caused by Whelton argued that these sources of data should not
be used interchangeably and suggested that there was asepsis was observed in diabetic patients in the GP (GP-
DM-S; Table 1), the overall trends in comparison to need to increase compatibility between these two infor-
mation systems to optimize their usefulness [21].patients with ESRD remained unaffected.
Our findings are in agreement with those outlined by One could argue that causes of death reported on
HCFA 2746 death notification forms may be more reli-Powe et al [16]. However, as shown on Figure 2A, female
nondiabetic ESRD patients had higher mortality rates able than death certificates, as patients with ESRD are
under more continuous medical follow-up comparedcompared with male nondiabetic patients across all age
groups. These observations were unadjusted. Interest- with patients in the GP. By contrast, the accuracy of the
death certificate’s completion is more likely to dependingly, a more recent study by Jaar et al found similar
trends in nondiabetic females; however, after adjustment on the availability of the patient’s primary care physician,
who is most informed about the patient’s medical condi-for demographic, comorbid, and laboratory parameters,
these analyses lost their statistical significance [19]. tion(s), and who should ideally be the one to complete
the death certificate [22]. Unfortunately, these scenariosThe major concern with the validity of our results is
the accuracy of mortality statistics in general, and in are not always encountered in clinical practice, as the
primary physician’s input may not always be obtained.particular, the comparative analyses between death cer-
tificates obtained from the GP with those of the HCFA- Since infectious disease deaths may be underclassified
as primary cause of death on the death certificate, webased ESRD registries. The latter tend to use customized
cause of death-reporting procedures. Few studies have performed a sensitivity analysis in which we assumed
that all patients who had sepsis documented anywhereattempted to explore the accuracy of death certificates
in the United States. One such study by Lloyd-Jones et al on the death certificate (whether it be the underlying
cause of death or not) died of sepsis. Furthermore, toexamined more than 2500 deceased Framingham Heart
Study participants, primarily for coding heart disease as minimize the risk of underreporting mortality secondary
to sepsis in the GP, we ran additional sensitivity analysesthe cause of death [20]. A panel of three physicians
reviewed all available medical information about each to evaluate the overall burden of infectious diseases on
mortality by globally analyzing the ICD-9 codes of adeath, including the study records, hospitalization re-
cords, and when available autopsy results. In the hands comprehensive list of infectious disease-related syn-
dromes reported on death certificates (Appendix). De-of these authors, the death certificate had a sensitivity
of 83.8% and a specificity of 84.1% for coronary heart spite these two “extreme” sensitivity analyses, the magni-
tude of the difference in mortality caused by sepsis indisease. Similar studies have been attempted to examine
the reliability of the HCFA 2746 death notification form patients with ESRD compared with the GP remained
extremely large (GP-S1, GP-S2; Table 1).among patients with ESRD. Indeed, Rocco et al have
argued that there is an overall good correlation between The USRDS collapses ESRD infectious causes of
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Appendix. Comprehensive list of infectious disease syndromes and related ICD-9 codes
Infectious disease syndromes ICD-9 codes
Septicemia; bacteremia 0.38.0–0.38.9; 790.7
Respiratory tract infections 460.0–466.1; 475.0; 480.0–487.8; 510.0–510.9; 513.0–513.1
Gastrointestinal tract infections 540.0–542.0; 566.0; 567.1–567.2; 569.5
Infections of the kidney and urinary tract 590.0–590.9; 599.0
Bacterial meningitis 027.0; 036.0–036.9; 320.0–324.9
Infections of the heart 391.0–391.9; 393; 394.1; 395.0–395.2; 397.9–398.9; 421.0–421.9; 422.9; 424.9
Tuberculosis 011.2–018.9; 137.0–137.3
Human immune deficiency virus infection 042.0–044.9; 279.1
Hepatobiliary infections 070.0–070.9; 576.1
Perinatal infections 090.2–090.9; 770.0; 771.0–771.8
Mycoses 110.0–117.9
